Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial

Ángel Lanas, Mónica Polo-Tomás, Luis A. García‐Rodríguez, Santiago García‐López, M Arroyo, Julio Ponce, Luís Bujanda, José Luís Calleja, Xavier Calvet, Faust Feu, Ángeles Pérez‐Aísa, Joseph J.�y. SungScandinavian 2013 · DOI

Abstract

The proportion of patients treated with i.v. esomeprazole in routine clinical practice who experienced further bleeding following endoscopic treatment for peptic ulcer bleeding was between the rates observed in the esomeprazole group and the placebo group in the RCT.
BibTeX
@inproceedings{lanas2013effect,
  author = {Ángel Lanas and Mónica Polo-Tomás and Luis A. García‐Rodríguez and Santiago García‐López and M Arroyo and Julio Ponce and Luís Bujanda and José Luís Calleja and Xavier Calvet and Faust Feu and Ángeles Pérez‐Aísa and Joseph J.�Y. Sung},
  title = {{Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial}},
  booktitle = {Scandinavian},
  year = {2013},
  doi = {10.3109/00365521.2012.758764},
}

Loading related content...

Figure